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ABSTRACT 
Objective: Aim of to present study was to assess drug utilization pattern of antibiotics use in Lower respiratory tract infection and their adverse 
drug reaction assessment. 
Methods: The present study was an observational and prospective study. 110 patients fulfill the inclusion criteria were included in study. Physician 
prescription records, patient’s medication profile types of antibiotics prescribed were recorded and analyzed. 
Results: Out of 110 LRTI patients, 74 (67.27%) patients were male and 36(32.72%) patients were female. 72 patients were suffered from 
bronchitis while 38 patients were suffering from pneumonia. 30 patients were in the age range of 56-65 y, followed by 21 patients who were in the 
age range of 66-75 y. It has been observed that among all the prescribed antibiotic agent's frequency of β-lactam 199(45.53%), quinolones115 
(26.27%), macrolides 53(12.12%) chloramphenicol44 (10.06%) sulphonamide 17 (3.89%) and aminoglycosides 9(2.05%) were prescribed to all 
the patients. Average 3.97 antibiotic agents were prescribed to all the patients. Majority of drugs were given by oral route (68.19%) and 
Prescriptions are mainly ordered in brand names. The most frequent co-morbid condition was found to be diabetes mellitus (25.45%) followed by 
hypertension (16.36%) and coronary artery disease (11.81%).45.45%. Only 23 ADRs were detected in 110 patients. The most common culprit was 
an amoxicillin with clavulanic acid. 
Conclusion: The present study provides an overall pattern of antibiotic usage in different patients. The area of concern in the present study is 
polypharmacy and use of antibiotics in LRTI without following any guideline. ADRs monitoring is also required to prevent noxious effects of drugs 
by the use of antibiotics.  
Keywords: Drug utilization Review, Adverse drug reaction (ADR), Lower respiratory tract infection (LRTI), Inpatient, Outpatient 




Lower respiratory tract infections (LRTIs) are the most common 
types of respiratory tract infections and it’s a common cause of 
morbidity and mortality. Although viruses are a frequent cause of 
LRTIs [1], these may lead to secondary bacterial infections such as 
bronchitis and pneumonia [2]. These bacteria namely; Streptococcus 
pneumonia, Haemophilus influenza, Klebsiella pneumonia 
Mycoplasma pneumonia Staphylococcus aureus and Chlamydia 
pneumonia are mainly responsible for infections [3]. Among these, 
the infections caused by S. pneumoniae are considered to be more 
responsible for morbidity and mortality among the patients [4]. 
Diseases of the LRTI affect the functioning of adults as well as 
children, usually with significant impairment of the daily life of 
affected patients [5]. It has been envisaged that with an increase in 
global population, infections remain the most important causes of 
disease, with LRTIs causing bronchitis and pneumonia learning 
disability, especially in adults. 
These were the fourth major cause of mortality and responsible for 
4.0 million deaths or 6.9% of a global number of deaths in 2002 [6]. 
The majority of the antibiotics were prescribed for LRTI with a 
presumed viral etiology such as pneumonia and acute bronchitis. 
The results from observation were showing that antibiotic 
prescriptions are made in approximately 40% of all consultations 
for pneumonia and in 80% of those for acute bronchitis. Antibiotics 
were prescribed in more than 90% of cases of pneumonia 
irrespective of the age of the patients. The condition differed for 
acute bronchitis infections as the number of consultations has 
remained unchanged over the last decade while antibiotic 
prescriptions have strongly increased, reaching 80% of the 
consultations [7]. The inconsistency of antibiotic prescription is 
attributable to real differences, from country to country or even 
region to region, of the infecting organisms and antimicrobial 
susceptibility, but other factors may also involve including physician 
preference, local policy, costs, lack of local proper guidelines [8].  
Currently, all over the world increase in resistant bacteria and 
simultaneously the downward tendency in the development of new 
antibiotics have serious health and economic issues. Throughout 
world an extensive overuse of antibiotics such as incorrect medical 
indications as well as misuse by using the wrong agent, route of 
administration, dose and treatment duration. Development of 
resistance is a natural biological consequence of antibiotic use. “Poor 
patient compliance with dosage regimens and the use of 
substandard antibiotics lead to suboptimal concentrations that fail 
to control the infections and it may promote the growth of resistant 
bacterial population thus, underuse, irrational use may play a vital 
role in driving resistance as overuse”. At present, the ideal antibiotic 
does not exist and the overuse of broad-spectrum agents in 
respiratory infections motivates resistance development in 
pathogenic bacteria as well as in the normal bacterial population to 
the patients [9]. The resistance problem is most prominent in Asian 
continent. Particular, the rates of resistant for pneumococci in Asian 
countries have been alarming. In India, almost 100% of the healthy 
population carries bacteria that are resistant to antibiotics [10].  
Even after the use of antibiotics for many years, there is little 
knowledge about how these drugs to be used optimally for the 
treatment. A core unanswered question is that how antibiotics 
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should be administered to minimize resistance development 
without compromising safety and efficacy. There is a need to 
study on both antibiotic uses and causes of use from all regions 
of the world. In too many countries there is inadequate 
surveillance of prescribing the drug, quality of the drug, and the 
resistance problem. As per European surveillance of antibiotics 
consumption (ESAC), significant improvements in the 
surveillance of antibiotics use in Europe have been succeeded. 
However, a global approach is needed where comparable data 
are generated [9].  
LRTIs infections place a considerable burden on the health care 
system and are generally more serious than upper respiratory 
infections. Since 2005 there has been a slight fall in the total 
number of loss of life from LRTI. However, in 2007, there was still 
the prominent cause of deaths among all infectious diseases 
accounting for 3.9 million deaths worldwide and 6.9% of total 
deaths that year [11]. Therefore, these evidence reflect drug 
utilization are required, as they evaluate the suitability of drug 
therapy. Drug use evaluation is an ongoing, authorized and 
systemic quality improvement process, which is designed to 
review the drugs which are prescribed to the patients, provide a 
right feedback to the clinician/ another relevant healthcare 
professional, develop criteria and standards; which describe 
optimal use of drug, promote suitable drug use through education 
and by counseling to the patients. Prospective drug utilization 
studies can directly impact the patient treatment and their 
outcome. 
MATERIALS AND METHODS 
It was prospective drug utilization evaluation and ADR monitoring 
of antibiotics in lower respiratory tract infections in Medicine 
Department, Majeedia Hospital, New Delhi-110062. 
Ethical approval 
The clinical protocol entitled “Drug utilization pattern and adverse 
drug reactions (ADRs) monitoring of antibiotics use in lower 
respiratory tract infections” was reviewed and approved by 
Institutional Review Board (IRB), Jamia Hamdard, New Delhi–
110062 ethical approval number is 24/01/011-02/11. 
Study site 
Study was carried out in the IPD and OPD of Medicine department of 
Majeedia Hospital; a 150 bedded teaching hospital situated in the 
premises of Jamia Hamdard New Delhi-110062. 
Study population 
Study was conducted on all eligible 110 patients at Majeedia 
Hospital, who had willingly participated; subjects were enrolled on 
the basis of inclusion and exclusion criteria. 
Selection of patients 
Inclusion criteria 
a. All patients using antibiotics visiting OPD and IPD of Medicine 
Department in Majeedia Hospital New Delhi 1100 62 
b. All the patients were included irrespective of age and sex. 
c. Pregnant and lactating patients were also included. 
Exclusion criteria 
a. Mentally retarded and unconscious patients. 
b. Patients who are not treated with antibiotics. 
c. Patients unable to comply. 
d. Drug addicts. 
Sources of data 
1) Physicians prescribing records. 
2) Patient’s medication profile. 
Evaluation of parameters 
The following parameters were evaluated:  
1. Types of antibiotics prescribed  
2. Average number of antibiotics per prescription  
3. Average age range of patients utilizing antibiotics 
4. Comparison of antibiotics prescribed in monotherapy vs. fixed-
dose combination therapy 
5. Comparison of antibiotics prescribing by generic vs. brand name 
6. Compliance or adherence (using Weekly Diary Cards) a criterion for 
non-compliance is <80% of recommended intake of prescribed drugs. 
7. Mode of administration of drugs 
8. Concomitant diseased conditions 
9. Most commonly used agents of a particular class 
10. Monitoring/recording of adverse drug reactions (ADRs) due to 
antibiotics. 
Informed consent form 
Written consent was obtained from the subjects participated in the 
study in the informed consent form, which is attached as Annexure I. 
Materials used 
Medication Utilization and ADR Monitoring (MUADRM) form, 
attached as annexure I and follow up form, attached as annexure II. 
Data collection 
The following data was collected based on the questionnaire. 
1. Patient profile (age, sex, weight, patient address, marital status). 
2. Drugs prescribed (generic/brand name) 
3. Drugs dose and frequency 
Written consent was obtained and interviews were conducted by 
using structured questionnaire (open question method). 
Weekly diary cards for daily drug intake to monitor adherence to 
prescribed dosage regimen was used. A criterion for non-compliance 
is<80% of recommended intake of the prescribed drug. Weekly 
diary card is attached as annexure III. 
RESULTS 
Distribution characteristics among study population 
A total of around 2100 patients (suffering from various diseases) visited 
the LRTI outpatient and inpatient in Medicine Department, Majeedia 
Hospital over a period of 4 mo. 110 patients suffering from bronchitis 
and pneumonia infections were selected for the present study. 
Demographic distribution amongst LRTI patients 
Among the 110 LRTI patients, 74 patients were male and 36 patients 
were female fig. 1. It was observed that 30 patients were in the age 
range of 56-65 y, followed by 21 patients who were in the age range 
of 66-75 y fig. 2 
Smokers vs. non-smokers and amongst LRTI patients 
32 patients were current smokers; amongst them 21 males and 11 
females. Among 59 patients were ex-smokers including 40 males 
and 19 females. 19 were non-smokers comprising 13 males and 6 
females table 1. 
Alcoholics vs. non-alcoholics and tobacco chewers vs. Non-
tobacco characteristics 
It was observed that 50 males and 16 females were alcoholics. 
Remaining 44 were Non-alcoholics including 24 males and 20 
females table 2. We found that 68 patients were tobacco chewers, 60 
amongst them were males and 8 were females table 2. 
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Fig. 1: Gender distribution amongst LRTI patients 
 
 
Fig. 2: Age distribution amongst LRTI patients 
 
Table 1: Smokers vs. non-smokers amongst LRTI patients among LRTI patients 
Smoking status No. of males No. of females Total 
Current smokers 21 11 32 
Ex-smokers 40 19 59 
Non smokers 13 6 19 
Total 74 36 110 
 
Table 2:Alcoholics Vs non-alcoholics and tobacco chewers Vs. non-tobacco chewers amongst LRTI patients 
Gender Alcoholic Non-alcoholic 
Male 50 (45.45%) 24 (21.81%) 
Female 16 (14.54%) 20 (18.18%) 
Total 66 (59.99%) 44 (39.99%) 
Gender Tobacco chewers Non-tobacco chewers 
Male 60 (54.54%) 14 (12.72%) 
Female 8 (7.27%) 28 (25.45%) 
Total 68 (61.81%) 42 (40.90%) 
 
Work status 
It was noted that 12 patients were employed, 8 were students, 11 
were housewives, 18 were a businessman, 30 were retired, and 15 
were unemployed and remaining 16 were others fig. 3. 
Types of infections 
Out of 110 patients, 72 patients suffered from bronchitis and 38 
patients were suffering from pneumonia table 3. 
Type of antibiotics prescribed 
During the study, it was observed that the most frequently 
prescribed antibiotic were β-lactam (199) followed by quinolones 
(115) macrolides (53) chloramphenicol (44) sulphonamide (17) 
cephalosporin (95) and aminoglycosides (9). Details of antibacterial 
utilization are given table 4. 
Most commonly used the agent of a particular class  
The most commonly used agent of the most commonly used class i.e., 
β-lactam was Penicillins-amoxicillin with clavulanic acid (91) and 
Cephalosporins-cefuroxime followed by quinolones-gemifloxacin (61) 
chloramphenicol (44) macrolides-azithromycin (40) Sulphonamide 
Co-trimoxazole (17) and aminoglycoside-neomycin with polymyxin B 
(6) table 5. 
Type of antibiotics therapy  
Prescription of patients showed that total of 60 patients received 
antibiotic monotherapy; whereas 18 patients were on multiple 
Ali et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 4, 7-14 
 
10 
drug therapy. Among those who were treated with drug 
combinations, 14 patients received two drugs; 8 patients 
received three drugs and 10 patients received four drug 
regimens table 6. 
 
 
Fig. 3: Work status amongst LRTI patients 
 
Table 3: Type of infection 
Infection Type No. of patients 
Bronchitis Acute Bronchitis 39 





Community-Acquired pneumonia 23 
Hospital Acquired pneumonia 15 
Total 38 
 Grand total  110 
 
Table 4: Type of antibiotics prescribed 
Class Antibiotics agents No. of agents prescribed % consumption 
Quinolones Ciprofloxacin 3 0.68 
Norfloxacin 2 0.45 
Ofloxacin 27 6.17 
Levofloxacin 4 0.91 
Gatifloxacin 18 4.11 
Gemifloxacin 61 13.95 
Total 115 26.27 
 Beta-lactams Penicillins   
 Amoxicillin 10 2.28 
 Amoxicillin+Clavulanic acid 91 20.82 
 Amoxicillin+Cloxacillin 3 0.68 
 Cephalosporins   
 Cefadroxil 5 1.14 
 Cefuroxime 23 5.26 
 Cefaclor 5 1.14 
 Cefdinir 8 1.83 
 Cefpodoximeproxetil 13 2.97 
 Cefixime 6 1.37 
 Cefixime+Cloxacillin 18 4.11 
 Cefpirome 15 3.43 
 Cefditroenpivoxil 2 0.45 
 Total 199 45.53 
Sulphonamide Co-trimoxazole 17 3.89 
 Total 17 3.89 
Chloramphenicol   44 10.06 
Aminoglycosides Gentamycin 3 0.68 
 
 
Tobramycin+Polymyxin B+Hydrocortisone 6 1.37 
Total 9 2.05 
Macrolides Azithromycin 40 9.15 
 Clarithromycin 13 2.97 
 Total 53 12.12 
Grand total  437 100% 
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Table 5: Most commonly used agent of a particular class 
Category Most commonly used agents No. of agent prescribed % consumption 
Beta-lactams 
Penicillins Amoxicillin with clavulanic acid 91 20.82 
Cephalosporins Cefuroxime 23 5.26 
Quinolones Gemifloxacin 61 13.95 
Chloramphenicol Chloramphenicol 44 10.06 
Macrolides Azithromycin 40 9.15 
Sulphonamide Co-trimoxazole 17 3.89 
Aminoglycosides Neomycin with polymyxin B 6 1.37 
 
Table 6: Type of antibiotics therapy 
Drugs prescribed No. of prescription % of prescription 
Single antibacterial agent (One drug) 60 54.54% 
Two drugs 14 12.72% 
Three drugs 8 7.27% 
Four drugs 10 9.09% 
More than four antibiotic agents 18 16.36% 
Total 110 100% 
 
Average number of antibacterial prescribed per patient per 
course 
The average number of antibiotic agents prescribed per patient per 
course was found to be 3.97 table 7. 
Routes of administration 
A total of 437 antibiotics were prescribed to110 patients. Their 
routes of administration were oral (298), parenteral (i. v) (81) and 
Topical (inhalation) (58) fig. 4. 
 
Table 7: Number of antibiotics agents prescribed per patient per course 
Total number of antibiotic agents 437 
Total number of patients 110 
Avg. no. of antibiotics agents prescribed per patient per course  3.97 
 
 
Fig. 4: Route of administration 
 
Concomitant conditions 
The most frequent concomitant conditions of the study population were 
found to be diabetes (25.45%) followed by hypertension (16.36%), 
coronary artery disease (11.81%) and others are mentioned in table 8. 
Comparison of prescribed antibiotics as generic vs. brand names 
All the antibiotics agents were prescribed by their brand names only. 
Patient's adherence 
Weekly diary cards were used for daily drug intake to monitor 
adherence to the prescribed dosage regimen. Criteria for non-
compliance were<80% of recommended intake of prescribed drugs 
table 9. 
Adverse drug reaction monitoring of antibiotics use inLRTI 
patients 
Adverse drug reaction monitoring was also carried out 
simultaneously in LRTI patients.  
ADRs among various age groups in LRTI patients 
The prevalence of ADRs was found to be highest in patients between 
56-65 y (26.08%) followed by 46-55 y (17.39%) fig. 5. 
Ali et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 4, 7-14 
 
12 
Table 8: Concomitant conditions 
Concomitant conditions No. of patients % of patients 
Diabetes 28 25.45% 
Hypertension 18 16.36% 
Coronary artery disease 13 11.81% 
Hypothyroidism 9 8.18% 
Rheumatoid arthritis 7 6.36% 
Depression 6 5.45% 
Tuberculosis 2 1.81% 
Epilepsy 2 1.81% 
CHF 1 0.90% 
Hyperthyroidism 1 0.90% 
Hypertension+Diabetes 2 1.81% 
Hypertension+R. arthritis 1 0.90% 
Diabetes+R. arthritis  1 0.90% 
Total 89 82.64% 
 
Table 9: Patients adherence 
Patients adherence Male Female % of patients 
<80% (Poor compliance) 50 10 54.54% 
≥ 80% (Good compliance) 20 30 45.45% 
50 of total patients showed a good adherence with the prescribed treatment. Adherence was found to be slightly better in females than in the male. 
 
 
Fig. 5: ADRs among various age groups in LRTI patients using antibiotics 
 
Table 10: ADRs and therapeutic medication 
Class Drugs Adverse reaction No. of ADRs Intervention 
Beta-lactams Amoxicillin+Clavulanic acid Loss of appetite 3 Symptomatic treatment was given 
Loss of appetite Symptomatic treatment was given 
Loss of appetite Symptomatic treatment was given 
Nausea/vomiting 2 Symptomatic treatment was given (antiemetic) 
Nausea/vomiting Symptomatic treatment was given (antiemetic) 
Breathing problem 1 Dechallenge 
Amoxicillin Epigastric distress 1 Symptomatic treatment was given (anta acid) 
Nausea/vomiting 1 Symptomatic treatment was given (antiemetic) 
Diarrhoea 1 Dechallenge 
Cefixime Urticaria 1 Dechallenge, Symptomatic treatment was given 
Cefaclor Skin rash 1 Dechallenge 
Quinolones Norfloxacin Abdominal pain 1 Symptomatic treatment was given 
Dizziness 1 Dechallenge 
Levofloxacin Headache 1 Symptomatic treatment was given 
Ofloxacin Vomiting 1 Symptomatic treatment was given (antiemetic) 
Gemifloxacin Diarrhoea 2 Dechallenge 
Diarrhoea  
Loss of appetite 2 Symptomatic treatment was given 
Loss of appetite Symptomatic treatment was given 
Macrolides Clarithromycin Altered taste 1 None 
Azithromycin Chest pain 1 Dechallenged 
Rash 1 Dechallenged 
Sulphonamide Co-timoxazole Folate deficiency 1 Symptomatic treatment was given 
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Table 11: Classification of ADRs according to Naranjo’s scale 
Assessment score No. of ADRs  % of ADRs  
UNLIKELY; ≤0 0 0% 
POSSIBLE; 1-4 15 65.21% 
PROBABLE; 5-8 8 34.78% 
HIGHLY PROBABLE; ≥9 0 0% 
Total 23 100% 
 
Gender distribution of ADRs 
A total of 23 ADRs were reported in LRTI patients. Among them 
14(60.86%) were male and 9 (39.13%) female. The percentage of 
patients experiencing ADRs was calculated from a pool of 110 
antibiotics prescribed cases. 
ADRs and therapeutic medication 
The details of ADRs associated with the individual antibiotics agent 
and their therapeutic classes observed in the study (table 10). 
Classification of ADRs on the basis of severity 
Majority of the ADRs (69.56%) observed were mild, which were well 
tolerated by the patients for e. g. nausea, GI distress, headache etc. 
30.43% of ADRs were classified as moderate e. g. diarrhoea with 
amoxicillin-clavulanic acid. The offending drug was withdrawn and 
specific/symptomatic treatment was given which reversed the 
symptoms as the shown table below. 
Classification of ADRs according to Naranjo’s scale 
Out of 23 ADRs, 15 (65%) were classified as possible and 8 (35%) 
ADRs were classified as probable as per Naranjo’s probability scale 
as shown table below table 11. 
DISCUSSION 
Prescription by a doctor may be taken as a reflection of physician’s 
attitude to the disease and role of the drug in treatment. It also 
provides an insight into the nature of the health care delivery 
system. The present prospective study indicated general trends of 
prescribing in the outpatient and inpatient department of Medicine, 
Majeedia Hospital, New Delhi-110062. 
During the study period of 4 mo, a total of 2100 patients (suffering 
from various diseases) visited the outpatient and inpatient 
department of Medicine, Majeedia Hospital. Out of these patients, 
only 110 patients met the inclusion criteria and were included in the 
study. Out of the total 110 patients, 74 (67.27%) were males and 36 
(32.72%) females as shown in the table 1. These observations are 
similar to other studies reported by [12, 13, 14] where the presence 
of males was found significantly more than females in various 
respiratory tract infection studies. In this study also, a higher 
percentage of males suffering from LRTIs. However, another study 
[15] has shown females more sensitive to LRTI infections than males 
being more exposed to kitchen smoke. 
In the present study, the age of the patients ranged from 6-85 y. 
Maximum number of patients 27.27% (30) was in the age group of 
56-65 y followed by the age group 66-75 y (19%). Our study 
indicates that LRTIs are more prevalent in older patients. Few 
studies have reported that majority of patient's fall in different age 
groups like 45-60 y and greater than 60 y with URTI [16]. Our 
results showed that LRTIs are predominant in older patients (age 
range 56-75 y).  
It was also observed that a total of 27.27% of patients were current 
smokers, 54.54% were ex-smoker and that male's presence was 
predominant in both the group. 45.45% of males and 14.54% of 
females were found alcoholic in our study. Alcoholism and tobacco 
chewing are major problems of developing countries, especially in 
the interiors of India. Since the majority of patients visiting Majeedia 
hospital were from backward areas like Sangam vihar, Tughlakabad 
extension etc, 61.8% of tobacco chewers including 54.54% of males 
were observed. The study included 78.18% of outpatients and only 
21.81% of inpatients at Majeedia Hospital. Out of these 110 patients, 
72 (65.45%) patients were found to be suffering from bronchitis 
(acute-39, chronic-33) and 38 patients were found suffering from 
pneumonia (community acquired-23, hospital-acquired-15). 
Bronchitis and pneumonia along with acute exacerbations are 
among the most common infections worldwide and a significant 
cause of morbidity and mortality [17]. The prevailing bacterial 
pathogens implicated in community-acquired LRTIs are S. 
pneumonia that is the most common causative agent of community-
acquired pneumonia (CAP).  
Most commonly prescribed categories of antibiotics were found to 
be β-lactam (44.83%) (Penicillin-23.1%, Cephalosporin-21.73%), 
followed by quinolones (26.27%) and macrolides (12.12%). The 
chloramphenicol and sulfonamides constituted only 10.06% and 
3.89% respectively. Among the individual antibiotics drugs, 
maximum patients had taken a combination of amoxicillin with 
clavulanic acid (20.82%), followed by gemifloxacin (13.95%), 
chloramphenicol (10.06%), azithromycin (9.15%), ofloxacin 
(6.17%) and cefuroxime (5.26%). In our study observed only 
12.12% of cases were prescribed such broad-spectrum antibiotics. A 
change in the prescribing patterns from a small spectrum to 
penicillin to amoxicillin-clavulanate, as indicative in our study. It 
could be due to an increase in antibiotic resistance which 
encourages physicians to choose a broader and safer option. We 
observed that 54.54% patients taken antibiotic monotherapy and 
the remaining patients were on multiple therapy receiving 2, 3 or 4 
drugs per prescription. The average number of antibiotic agent 
prescribed per patient per course was found to be 3.97. An average 
of 3.75 drugs per prescription indicates polypharmacy. Since it 
increases the risk of adverse effect, drug interaction increases cost 
and reduce patient compliance; it is an area of concern requiring 
intervention. 
The routes of administration of antibiotics were found to be oral 
(81.81%), parenteral (9.09%) and topical (inhalation) (9.09%). It 
has been observed that the trend of prescribing drugs under the 
generic name is declining [15]. We found that none of the drugs was 
prescribed by generic names. Such practice may be an evidence of 
vigorous promotional strategies by pharmaceutical companies. It 
may undermine some of the goals of essential drug concept. On the 
other hand, prescribing by generic name may reduce overall 
expenditure on drugs especially on newer antibiotics etc. The 
practice of prescribing drugs by brand name thus should be 
discouraged as the use of generic is a cheaper alternative. 
A significant number of patients (82.64%) were found to be 
suffering from concomitant diseases. The most frequent 
concomitant condition of the study population was found to be 
diabetes (25.45%), followed by hypertension (16.36%), coronary 
artery disease (11.81%), hypothyroidism (8.81%) and rheumatoid 
arthritis (3.63%). Further, only 50 (45.45%) patients had taken the 
drug properly. For studying patients compliance weekly diary cards 
where used. Cost of antibiotic could be one of the important factors 
for noncompliance in developing countries like India. Inadequate 
information about the disease, adverse effect of the drugs, use 
instructions and cautions are the other reasons of patients non-
compliance [18].  
We evaluated the safety of the treatment by monitoring the ADRs 
throughout the study period. Only 20.91% of patients had 
complaints of ADRs. The prevalence of ADR was found to be highest 
in patients between 56-65 y followed by 46-55 y (17.39%). Most of 
the ADRs were mild (69.56%) such as nausea, vomiting, loss of 
appetite etc. (30.43%) were moderate such as diarrhea. Maximum 
ADRs were reported with the combination of amoxicillin and 
Ali et al. 
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clavulanic acid 30.40% followed by gemifloxacin (17.4%). Diarrhea is 
a common side effect of antibiotic therapy. In the present study, 
either the antibiotic therapy was de challanged or symptomatic 
treatment was a given for most of the ADRs reported which reversed 
the symptoms. ADRs were assessed using Naranjo’s probability scale 
which showed that 15 ADRs (65.21%) were a possible reaction and 
8 (34.78%) were a probable reaction. This study showed that most 
of the ADRs were mild (69.56%). None of the ADRs was severe or 
life-threatening. 
CONCLUSION 
It concluded that it is preferable to keep the lesser utilization of 
antibiotics in LRTI infection since some of the LRTIs are not due to 
bacteria. Prescribing drug by generic name and not by brand name 
could lead to cheaper treatments. It appears that majority of the 
LRTIs coming to the hospital are primarily due to bacteria, most of 
the patients responded well with the use of antibiotics. Majority of 
the patients used drug regimen to the current treatment guidelines. 
The study highlighted some rational prescription patterns including 
the lesser rate of injection in OPD. The area of concern is 
polypharmacy, high rate of antibiotic prescribing etc. Initiative must 
be taken to minimize polypharmacy concerning to the antibiotics 
prescribing for LRTI infections. 
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